Preferred Label : Brown-vialetto-van laere syndrome 2;
Symbol : BVVLS2;
CISMeF acronym : BVVLS2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : RTD2; Riboflavin transporter deficiency, type 2;
Description : Brown-Vialetto-Van Laere syndrome-2 is an autosomal recessive progressive neurologic
disorder characterized by early childhood onset of sensorineural deafness, bulbar
dysfunction, and severe diffuse muscle weakness and wasting of the upper and lower
limbs and axial muscles, resulting in respiratory insufficiency. Some patients may
lose independent ambulation. Because it results from a defect in riboflavin metabolism,
some patients may benefit from high-dose riboflavin supplementation (summary by Johnson
et al., 2012 and Foley et al., 2014). See also BVVLS1 (211530), caused by mutation
in the SLC52A3 gene (613350).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the solute carrier family 52 (riboflavin transporter), member
2 gene (SLC52A2, 607882.0001);
Laboratory abnormalities : Abnormal acylcarnitine profiles; Organic aciduria;
Prefixed ID : #614707;
Origin ID : 614707;
UMLS CUI : C3553538;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)